# DESCRIPTION

## FIELD OF THE DISCLOSED SUBJECT MATTER

- introduce organ transplantation

## BACKGROUND OF THE DISCLOSED SUBJECT MATTER

- motivate organ transplantation
- describe current transplant procedures
- highlight donor organ shortage
- discuss limitations of current preservation techniques
- describe extracorporeal membrane oxygenation
- introduce initiatives to increase transplantable lungs
- describe ex vivo lung perfusion
- discuss xenogeneic lungs
- highlight limitations of current EVLP systems
- describe current organ preservation techniques
- highlight need for improved preservation techniques
- describe benefits of physiologic preservation
- discuss limitations of conventional extracorporeal support systems
- highlight need for improved extracorporeal support systems

## SUMMARY

- introduce normothermic extracorporeal support
- describe cross-circulation perfusion
- highlight prolonged support periods
- describe extracorporeal host connection
- introduce system for maintaining extracorporeal organ
- describe extracorporeal chamber
- highlight auto-regulation of blood flow
- describe extracorporeal cross-circulation circuit
- introduce pressure-controlled blood flow
- describe integrated heat exchanger
- highlight remote monitoring capability
- describe extracorporeal organ chamber stand
- introduce automatic height adjustability
- describe organ-specific accessories
- highlight rechargeable power source back-up
- describe biologic cuff device
- introduce native vessel as biological bridge
- describe draining cannula
- highlight patient safety clamp
- describe automatic clamping mechanism
- introduce method for normothermic extracorporeal support
- describe treating extracorporeal organ with acute injury
- highlight transplanting extracorporeal organ

## DETAILED DESCRIPTION OF THE DISCLOSED SUBJECT MATTER

- introduce cross-circulation support of extracorporeal organs
- describe limitations of current organ transplant methods
- motivate long-term preservation of organs
- describe the invention's capabilities
- outline various applications of the invention
- describe the mobile platform or system for prolonged extracorporeal support
- detail the connection between the host and extracorporeal organ
- describe the system's uses for recovery, regeneration, and maintenance of organs
- outline additional research applications
- describe the system's use for cross-circulation between the organ recipient and donor organ
- describe the use of a healthy animal as a cross-circulation host
- describe the system's application for the recovery of injured human donor organs
- introduce the human-xenogeneic bioreactor application
- describe the benefits of the human-xenogeneic bioreactor
- outline additional uses of the human-xenogeneic bioreactor
- describe the cross-circulation platform's opportunities for organ recovery
- describe the systems, methods, and devices for cross-circulation support of extracorporeal organs
- outline envisioned uses of cross-circulation
- describe the benefits of cross-circulation over conventional EVLP
- describe the cross-circulation circuit
- detail the fluid conduits and auto-regulation of blood flow
- describe the integrated circuit elements
- introduce FIG. 1A and 1B
- describe the cross-circulation system components
- introduce FIG. 11
- describe the cross-circulation circuit diagram
- introduce FIG. 2
- describe the system for cross-circulation of plasma
- introduce FIGS. 3A to 3E
- describe the organ chamber basin
- introduce FIG. 4A to 4C
- describe the extracorporeal organ, tissue, or bioengineered graft chamber
- introduce FIGS. 5A and 5B
- describe the control of cross-circulation perfusion
- introduce FIG. 6A to 6C
- describe the organ cart or stand
- introduce FIG. 7A to 7E
- describe the biologic cuff device
- introduce FIGS. 8A to 8H
- describe the use of a biologic cuff device for single lung venous cannulation
- introduce FIGS. 9A to 9E
- describe vascular components of the biologic cuff device
- introduce FIGS. 10A to 10C
- describe crenellated or self-expanding stenting drainage cannulas
- describe the pre-clinical swine model of cross-circulation
- describe haemodynamic stability
- measure biochemical analysis
- measure haemolytic markers
- measure pro-inflammatory markers
- measure anti-inflammatory markers
- describe extracorporeal lung performance
- measure trans-pulmonary pressure gradient
- measure pressure volume loops
- measure dynamic compliance
- measure clearance of lactate
- measure PaO2/FiO2 ratios
- describe responses to performance challenges
- analyze lung weight
- analyze trans-pulmonary pressure gradient
- analyze pressure-volume loops
- analyze dynamic compliance
- analyze lactate accumulation
- analyze PaO2/FiO2 ratios
- analyze responses to performance challenges
- describe extracorporeal lung analysis
- analyze macroscopic appearance
- analyze airway bronchoscopy
- analyze histologic analysis
- analyze scanning electron microscopy
- analyze transmission electron microscopy
- analyze metabolic activity
- analyze functional analyses
- analyze vasoresponsiveness
- analyze integrity of microvascular endothelium
- analyze neutrophils
- analyze macrophage quantification
- describe extracorporeal lung analysis for ischaemic recovery group
- analyze macroscopic analysis
- analyze bronchoscopy
- analyze assessment of airway inflammation
- analyze BAL fluid
- measure inflammatory markers
- demonstrate multiscale interventions
- develop compact transpleural imaging system
- deliver microbeads and MSCs
- demonstrate feasibility of replacing lung epithelium
- decellularize targeted bronchopulmonary segments
- deliver pulmonary epithelial cells
- maintain viable extracorporeal lungs
- recover lungs subjected to ischaemia reperfusion injury
- provide benefits to extracorporeal lung
- extend duration of normothermic support
- develop strategies for prolonged extracorporeal organ support
- manage pulmonary venous drainage
- maintain physiologic trans-pulmonary pressure gradient
- establish recipient safety
- assess ability of cross-circulation to recover damaged lungs
- analyze inflammatory cytokines in serum and BAL fluid
- assess preservation of lung integrity and function
- demonstrate significant increase in anti-inflammatory IL-10
- reduce lung weight and airway oedema
- recover cellular and structural integrity
- enable interventions not currently feasible ex vivo
- develop targeted micro-volume delivery techniques
- enable directed region-specific interventions
- demonstrate global, single-lobe and subsegmental delivery of MSCs
- investigate prolonged cross-circulation between unrelated donor and recipient swine
- assess ability of cross-circulation to rescue severely damaged lungs
- envision clinical applications of cross-circulation

## EXAMPLES

### Methods

- design pilot study
- state hypothesis
- describe study conduct
- explain randomization of sampling
- describe blinded review
- introduce animals
- describe animal selection
- describe animal care
- introduce donor lung harvest
- describe anaesthesia
- describe heparin administration
- describe cannula placement
- describe lung storage for prolonged cold ischaemia
- describe lung cannulation and conventional EVLP
- describe circuit priming
- describe ventilation initiation
- describe atelectatic lung region recruitment
- introduce cross-circulation
- describe recipient preparation
- describe circuit connection
- describe physiological parameter monitoring
- describe blood analysis
- describe extracorporeal lung monitoring
- describe HAL analysis
- describe BODIPY-surfactant uptake method
- detail vasoconstriction/responsiveness test
- outline metabolic activity assay
- describe myeloperoxidase activity assay
- detail live cilia imaging method
- outline immunohistochemical staining
- describe histopathologic analysis
- detail blinded pathologic review
- outline thermal imaging
- describe electron microscopy
- detail scanning electron microscopy
- outline transmission electron microscopy
- describe therapeutic delivery into extracorporeal lung
- detail decellularization of target lung regions
- outline delivery of mesenchymal stem cells
- describe cell delivery using bronchoscope
- detail live transpleural imaging of near-infrared-labelled cells
- outline delivery of CSFE and fluorescent microbeads
- describe delivery of human airway epithelial cells
- detail delivery of human embryonic stem cell-derived alveolar progenitor cells
- outline statistical analysis
- describe one-way analysis of variance test
- detail Tukey's multiple comparison post hoc tests
- outline Student's t-tests
- describe significance of p-value
- outline modification of described embodiments
- describe scope of invention
- detail application of principles
- outline embodiments of invention
- claim invention

